Sandoz To Launch Tyruko Biosimilar For Multiple Sclerosis In Germany On Feb. 1

(RTTNews) - Sandoz (SDZNY), a maker of generic and biosimilar medicines, announced Wednesday the launch of Tyruko (natalizumab) in Germany from Fe...

Related Keywords

Germany ,Rebecca Guntern ,Polpharma Biologics ,European Commission ,More Such Health News ,President Europe ,